🏛️ Verified NIH Record • Updated 2025-06-05
Validation of a Multi-gene Test for Lung Cancer Risk (NCT01130285)
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: University of Toledo Health Science Campus
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to determine the validity of a multi-gene Lung Cancer Risk Test (LCRT). In the process, the investigators will establish a bank of NBEC samples and corresponding blood samples from individuals demographically at increased risk for lung cancer.
Who can join: Review the eligibility criteria below.
Location: National Jewish Health — Denver, Colorado
Age range: 50 Years to 90 Years
🧪 Interventions in This Study
- Lung Cancer Risk Test (GENETIC)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (13 Sites)
- National Jewish Health — Denver, Colorado
- University of Michigan — Ann Arbor, Michigan
- Henry Ford — Detroit, Michigan
- Mayo Clinic — Rochester, Minnesota
- Cleveland Clinic Foundation — Cleveland, Ohio
- Ohio State University — Columbus, Ohio
- The Toledo Hospital — Toledo, Ohio
- Mercy St. Vincent Medical Center — Toledo, Ohio
- University of Toledo, Health Science Campus — Toledo, Ohio
- Medical University of South Carolina — Charleston, South Carolina
- Tennessee Valley Veterans Admin. — Nashville, Tennessee
- Vanderbilt — Nashville, Tennessee
- Inova Fairfax Hospital — Falls Church, Virginia
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Lung Cancer
- Implementation Strategies for Monitoring Adherence in Real Time — Philadelphia, Pennsylvania
- Early Detection of Lung Cancer — Nashville, Tennessee
- Improving Utilization of Lung Cancer Screening in Underserved PA Populations — Allentown, Pennsylvania
- Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer Setting — Houston, Texas
- Testing the Engaged Approach to Lung Cancer Screening — Denver, Colorado
- Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer — Boston, Massachusetts
Explore by condition: All Lung Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.